documents: FDA-2023-N-2177-0085
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-2177-0085 | FDA | FDA-2023-N-2177 | Reference 42 - American Cancer Society Cancer Action Network - Administration Declines to Issue FDA Guidance on LDT Oversight RE: Medical Devices; Laboratory Developed Tests | Supporting & Related Material | Background Material | 2023-10-04T04:00:00Z | 2023 | 10 | 2023-10-10T14:00:52Z | 0 | 0 | 09000064860259cf |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref